Leukocyte_NN
populations_NNS
,_,
hormone_NN
receptors_NNS
and_CC
apoptosis_NN
in_IN
eutopic_JJ
and_CC
ectopic_JJ
first_JJ
trimester_NN
human_JJ
pregnancies_NNS
._.

The_DT
implantation_NN
of_IN
trophoblast_NN
cells_NNS
at_IN
extrauterine_JJ
sites_NNS
still_RB
results_VBZ
in_IN
decidualization_NN
._.

The_DT
objective_NN
of_IN
the_DT
present_JJ
study_NN
was_VBD
to_TO
compare_VB
decidualization_NN
at_IN
eutopic_JJ
and_CC
ectopic_JJ
implantation_NN
sites_NNS
._.

Tissues_NNS
from_IN
women_NNS
undergoing_VBG
elective_JJ
termination_NN
of_IN
uterine_JJ
pregnancy_NN
and_CC
from_IN
women_NNS
with_IN
ectopic_JJ
pregnancy_NN
were_VBD
used_VBN
to_TO
detect_VB
the_DT
presence_NN
of_IN
cells_NNS
important_JJ
for_IN
the_DT
maintenance_NN
of_IN
pregnancy_NN
,_,
such_JJ
as_IN
BCL-2_NN
+_NN
,_,
CD56_NN
+_NN
,_,
CD3_NN
+_NN
,_,
CD8_NN
+_JJ
and_CC
CD68_NN
+_JJ
cells_NNS
,_,
and_CC
the_DT
presence_NN
of_IN
estrogen_NN
-LRB-_-LRB-
ER_NN
-RRB-_-RRB-
and_CC
progesterone_NN
receptors_NNS
-LRB-_-LRB-
PR_NN
-RRB-_-RRB-
by_IN
immunohistochemistry_NN
._.

In-situ_FW
detection_NN
of_IN
fragmented_JJ
DNA_NN
was_VBD
performed_VBN
to_TO
identify_VB
apoptotic_JJ
cells_NNS
._.

The_DT
percentage_NN
of_IN
CD3_NN
+_CC
cells_NNS
among_IN
all_DT
immunocompetent_JJ
cells_NNS
in_IN
the_DT
tubal_JJ
epithelium_NN
was_VBD
46.6_CD
%_NN
-LRB-_-LRB-
39.9_CD
%_NN
of_IN
CD3_NN
+_NN
were_VBD
also_RB
CD8_NN
+_JJ
-RRB-_-RRB-
;_:
the_DT
other_JJ
53.4_CD
%_NN
were_VBD
CD68_NN
+_CC
cells_NNS
._.

CD56_NN
+_CC
cells_NNS
were_VBD
undetectable_JJ
in_IN
ectopic_JJ
decidua_NN
at_IN
the_DT
feto-maternal_JJ
interface_NN
in_IN
ectopic_JJ
tissue_NN
._.

In_IN
uterine_JJ
decidua_NN
,_,
we_PRP
found_VBD
29.9_CD
%_NN
CD3_NN
+_CC
cells_NNS
-LRB-_-LRB-
2.2_CD
%_NN
of_IN
CD3_NN
+_NN
were_VBD
CD8_NN
+_JJ
-RRB-_-RRB-
,_,
51.6_CD
%_NN
CD56_NN
+_CC
cells_NNS
and_CC
18.5_CD
%_NN
CD68_NN
+_CC
cells_NNS
._.

The_DT
ratio_NN
of_IN
BCL2_NN
+_NN
to_TO
CD3_NN
+_CC
cells_NNS
in_IN
ectopic_JJ
pregnancy_NN
was_VBD
0.41_JJ
._.

In_IN
uterine_JJ
pregnancy_NN
,_,
the_DT
ratio_NN
of_IN
BCL-2_NN
to_TO
CD3_NN
was_VBD
0.44_CD
and_CC
0.39_CD
for_IN
CD56_NN
._.

Tissues_NNS
from_IN
both_CC
ectopic_JJ
and_CC
uterine_JJ
pregnancies_NNS
were_VBD
positive_JJ
for_IN
PR_NN
._.

Fewer_JJR
apoptotic_JJ
cell_NN
bodies_NNS
were_VBD
present_JJ
in_IN
ectopic_JJ
pregnancy_NN
._.

The_DT
use_NN
of_IN
tissue_NN
obtained_VBN
from_IN
ectopic_JJ
pregnancy_NN
may_MD
become_VB
an_DT
excellent_JJ
model_NN
to_TO
identify_VB
the_DT
mechanism_NN
of_IN
trophoblast_NN
invasion_NN
in_IN
eutopic_JJ
pregnancies_NNS
._.

